FDA NDC Directory · JSON-LD · Markdown

Irbesartan and Hydrochlorothiazide

NDC 43547-331 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerSolco Healthcare US, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA203072
Dosage form / routeTABLET · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (12.5 mg/1)
IRBESARTAN (300 mg/1)
Marketing started20140301
Package count3

External sources

Source: openFDA. Public-domain (CC0).